AUTHOR=Zhang Rui , Liu Baoshan , Fan Xinhui , Wang Wenjun , Xu Tonghui , Wei Shujian , Zheng Wen , Yuan Qiuhuan , Gao Luyao , Yin Xinxin , Zheng Boyuan , Zhang Chuanxin , Zhang Shuai , Yang Kehui , Xue Mengyang , Wang Shuo , Xu Feng , Wang Jiali , Cao Yihai , Chen Yuguo TITLE=Aldehyde Dehydrogenase 2 Protects Against Post-Cardiac Arrest Myocardial Dysfunction Through a Novel Mechanism of Suppressing Mitochondrial Reactive Oxygen Species Production JOURNAL=Frontiers in Pharmacology VOLUME=11 YEAR=2020 URL=https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2020.00373 DOI=10.3389/fphar.2020.00373 ISSN=1663-9812 ABSTRACT=
Post-cardiac arrest myocardial dysfunction significantly contributes to early mortality after the return of spontaneous circulation. However, no effective therapy is available now. Aldehyde dehydrogenase 2 (ALDH2) enzyme has been shown to protect the heart from aldehyde toxicity such as 4-hydroxy-2-nonenal (4-HNE) and oxidative stress. In this study, we evaluated the effect of enhanced activity or expression of ALDH2 on post-cardiac arrest myocardial dysfunction and survival in a rat cardiac arrest model. Furthermore, we elucidated the underlying mechanisms with a focus on mitochondrial reactive oxygen species (ROS) production in a cell hypoxia/reoxygenation model. A total of 126 rats were used for the ALDH2 activation or cardiac overexpression of ALDH2 studies. Randomization was done 10 min before the respective agonist injection or